TY - JOUR
T1 - Resident PW1+ progenitor cells participate in vascular remodeling during pulmonary arterial hypertension
AU - Dierick, France
AU - Héry, Tiphaine
AU - Hoareau-Coudert, Bénédicte
AU - Mougenot, Nathalie
AU - Monceau, Virginie
AU - Claude, Caroline
AU - Crisan, Mihaela
AU - Besson, Vanessa
AU - Dorfmüller, Peter
AU - Marodon, Gilles
AU - Fadel, Elie
AU - Humbert, Marc
AU - Yaniz-Galende, Elisa
AU - Hulot, Jean Sébastien
AU - Marazzi, Giovanna
AU - Sassoon, David
AU - Soubrier, Florent
AU - Nadaud, Sophie
N1 - Funding Information:
This work was supported by Institute of Cardiometabolism and Nutrition (ANR-10-IAHU-05). D. Sassoon, G. Marodon, and J.-S. Hulot are supported by a grant from the Fondation Leducq (grant 13CVD01; CardioStemNet project). S. Nadaud acknowledges support from the Agence Nationale de la Recherche (ANR-15-CE14-0020-01). F. Dierick was supported by the French Ministry of Research and Education. This project also received support from OPTISTEM (optimization of stem cell therapy for degenerative epithelial and muscle diseases contract number Health-F5-2009-223098) and ENDOSTEM (activation of vasculature associated stem cells and muscle stem cells for the repair and maintenance of muscle tissueagreement number 241440). D. Sassoon acknowledges support from the Institut Pasteur and the Agence Nationale de la Recherche (Laboratoire d''Excellence Revive, Investissement d''Avenir; ANR-10-LABX-73). M Humbert acknowledges support from the Assistance Publique Hôpitaux de Paris (Département Hospitalo-Universitaire Thorax Innovation, DHU TORINO) and the Agence Nationale de la Recherche (Labex LERMIT).
Publisher Copyright:
© 2016 American Heart Association, Inc.
PY - 2016/3/4
Y1 - 2016/3/4
N2 - Rationale: Pulmonary arterial hypertension is characterized by vascular remodeling and neomuscularization. PW1+ progenitor cells can differentiate into smooth muscle cells (SMCs) in vitro. Objective: To determine the role of pulmonary PW1+ progenitor cells in vascular remodeling characteristic of pulmonary arterial hypertension. Methods and Results: We investigated their contribution during chronic hypoxia-induced vascular remodeling in Pw1nLacZ+/-mouse expressing β-galactosidase in PW1+ cells and in differentiated cells derived from PW1+ cells. PW1+ progenitor cells are present in the perivascular zone in rodent and human control lungs. Using progenitor markers, 3 distinct myogenic PW1+ cell populations were isolated from the mouse lung of which 2 were significantly increased after 4 days of chronic hypoxia. The number of proliferating pulmonary PW1+ cells and the proportion of β-gal+ vascular SMC were increased, indicating a recruitment of PW1+ cells and their differentiation into vascular SMC during early chronic hypoxia-induced neomuscularization. CXCR4 inhibition using AMD3100 prevented PW1+ cells differentiation into SMC but did not inhibit their proliferation. Bone marrow transplantation experiments showed that the newly formed β-gal+ SMC were not derived from circulating bone marrow-derived PW1+ progenitor cells, confirming a resident origin of the recruited PW1+ cells. The number of pulmonary PW1+ cells was also increased in rats after monocrotaline injection. In lung from pulmonary arterial hypertension patients, PW1-expressing cells were observed in large numbers in remodeled vascular structures. Conclusions: These results demonstrate the existence of a novel population of resident SMC progenitor cells expressing PW1 and participating in pulmonary hypertension-associated vascular remodeling.
AB - Rationale: Pulmonary arterial hypertension is characterized by vascular remodeling and neomuscularization. PW1+ progenitor cells can differentiate into smooth muscle cells (SMCs) in vitro. Objective: To determine the role of pulmonary PW1+ progenitor cells in vascular remodeling characteristic of pulmonary arterial hypertension. Methods and Results: We investigated their contribution during chronic hypoxia-induced vascular remodeling in Pw1nLacZ+/-mouse expressing β-galactosidase in PW1+ cells and in differentiated cells derived from PW1+ cells. PW1+ progenitor cells are present in the perivascular zone in rodent and human control lungs. Using progenitor markers, 3 distinct myogenic PW1+ cell populations were isolated from the mouse lung of which 2 were significantly increased after 4 days of chronic hypoxia. The number of proliferating pulmonary PW1+ cells and the proportion of β-gal+ vascular SMC were increased, indicating a recruitment of PW1+ cells and their differentiation into vascular SMC during early chronic hypoxia-induced neomuscularization. CXCR4 inhibition using AMD3100 prevented PW1+ cells differentiation into SMC but did not inhibit their proliferation. Bone marrow transplantation experiments showed that the newly formed β-gal+ SMC were not derived from circulating bone marrow-derived PW1+ progenitor cells, confirming a resident origin of the recruited PW1+ cells. The number of pulmonary PW1+ cells was also increased in rats after monocrotaline injection. In lung from pulmonary arterial hypertension patients, PW1-expressing cells were observed in large numbers in remodeled vascular structures. Conclusions: These results demonstrate the existence of a novel population of resident SMC progenitor cells expressing PW1 and participating in pulmonary hypertension-associated vascular remodeling.
KW - Adult stem cells
KW - Hypertension, pulmonary
KW - Hypoxia
KW - Muscle, smooth, vascular
KW - vascular remodeling
UR - http://www.scopus.com/inward/record.url?scp=84954447732&partnerID=8YFLogxK
U2 - 10.1161/CIRCRESAHA.115.307035
DO - 10.1161/CIRCRESAHA.115.307035
M3 - Article
C2 - 26838788
AN - SCOPUS:84954447732
SN - 0009-7330
VL - 118
SP - 822
EP - 833
JO - Circulation Research
JF - Circulation Research
IS - 5
ER -